BICYCLE THERAPEUTICS PLC — Director's Dealing 2021

Dec 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2021-12-21

Reporting Person: Keen Nicholas (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-21	Ordinary Shares	M	15477	$14.00	Acquired	15477	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-21	Stock Option (Right to Buy)	$14.00	M	15477	Disposed	2029-06-28	Ordinary Shares (15477)	Direct

Footnotes

F1: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant.